ASTRAZENECA A/S: Financial statements 2015
CVR: 55742928
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
ASTRAZENECA A/S (CVR 55742928) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 171,247,000 and a net result of DKK 2,524,000 compared with DKK 5,398,000 the year before. That is a decrease of 21.2% compared with the year before. The profit margin was 1.5%. Equity in the 2015 report amounted to DKK 132,526,000. The solvency ratio was 75.9%. The company had 77 employees in the financial year.
- Revenue
- DKK 171,247,000
- Gross Profit
- DKK 76,004,000
- Profit/Loss
- DKK 2,524,000
- Equity
- DKK 132,526,000
- Total Assets
- DKK 174,647,000
- Employees
- 77
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 171.2 mio. | 76 mio. | 2.5 mio. | 132.5 mio. | 77 |
| 2014 | 217.2 mio. | 77.9 mio. | 5.4 mio. | 130 mio. | 70 |
| 2013 | 201.5 mio. | 74.6 mio. | 5.8 mio. | 124.6 mio. | 102 |
Official annual report
How creditworthy is ASTRAZENECA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of November 1, 2015, Julie Enevold Brooker is registered as adm. dir. of ASTRAZENECA A/S.
As of November 1, 2015, Susanne Skovgaard Nickelsen has stepped down as adm. dir. of ASTRAZENECA A/S.
ASTRAZENECA A/S has published its annual report for 2014. Revenue came to DKK 217,216,000, and the net result was DKK 5,398,000.
About ASTRAZENECA A/S
ASTRAZENECA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1943. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Christof Josef Bischoff. The board consists of Emelie Karin Susanne Antoni (chair), Charlotte Ivang Ladefoged, Christof Josef Bischoff and Erik Jesper Bergkvist. The company is owned by AstraZeneca Continent BV and AstraZeneca AB. The company has 71 employees (2018). In 2025, the company reported revenue of DKK 630,320,000 and a net result of DKK 24,203,000 compared with DKK 6,241,000 the year before. Equity in the 2025 report amounted to DKK 226,831,000.